World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
73
Citations
26556
World Ranking
5822
National Ranking
2757

Sarat Chandarlapaty publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Sarat Chandarlapaty sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 279 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Sarat Chandarlapaty D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Sarat Chandarlapaty sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 73 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Sarat Chandarlapaty is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans across the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with significant contributions within oncology and related subfields.

The scientist's work is disseminated through frequent publications in well-recognized venues, including:

  • Cancer Research
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Annals of Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)

The main subfields that define their research focus include:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Molecular Biology
  • Genetics

The core topics of their investigations emphasize:

  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Cancer Genomics and Diagnostics
  • Cancer Treatment and Pharmacology
  • Breast Cancer Treatment Studies
  • PI3K/AKT/mTOR signaling in cancer
  • Estrogen and related hormone effects

Selected recent publications include:

  • "Unlocking the potential of antibody-drug conjugates for cancer therapy" (2021) published in Nature Reviews Clinical Oncology
  • "Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients" (2022) published in Cell
  • "Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS" (2021) published in Nature Communications
  • "Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors" (2020) published in Nature Cancer
  • "Independent real-world application of a clinical-grade automated prostate cancer detection system" (2021) published in The Journal of Pathology

Frequent coauthors collaborating with Sarat Chandarlapaty include:

  • Pedram Razavi
  • Jorge S. Reis-Filho
  • Fresia Pareja
  • Anton Safonov
  • Britta Weigelt

Best Publications

  • OncoKB: A Precision Oncology Knowledge Base.

    Debyani Chakravarty;Jianjiong Gao;Sarah Phillips;Ritika Kundra

  • Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer

    Brett S. Carver;Caren Chapinski;John Wongvipat;Haley Hieronymus

  • ESR1 ligand-binding domain mutations in hormone-resistant breast cancer

    Weiyi Toy;Yang Shen;Helen Won;Bradley Green

  • AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity

    Sarat Chandarlapaty;Ayana Sawai;Maurizio Scaltriti;Vanessa Rodrik-Outmezguine

  • The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.

    Pedram Razavi;Matthew T. Chang;Guotai Xu;Chaitanya Bandlamudi

  • Unlocking the potential of antibody-drug conjugates for cancer therapy.

    Joshua Z. Drago;Shanu Modi;Shanu Modi;Sarat Chandarlapaty;Sarat Chandarlapaty

  • Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas

    Piro Lito;Christine A. Pratilas;Eric W. Joseph;Madhavi Tadi

  • PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

    V. Serra;M. Scaltriti;L. Prudkin;Pieter Eichhorn

  • HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies

    Devika Gajria;Sarat Chandarlapaty

  • Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer

    Gaia Schiavon;Gaia Schiavon;Sarah Hrebien;Isaac Garcia-Murillas;Rosalind J. Cutts

  • HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab

    Shanu Modi;Alison T. Stopeck;Hannah M. Linden;David B. Solit

  • mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling

    Vanessa S. Rodrik-Outmezguine;Sarat Chandarlapaty;Nen C. Pagano;Poulikos I. Poulikakos

  • Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial.

    Sarat Chandarlapaty;David Chen;Wei He;Patricia Sung

  • Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

    Sharon H. Giordano;Sarah Temin;Jeffrey J. Kirshner;Sarat Chandarlapaty

  • Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway

    Zhiqiang Li;Pedram Razavi;Pedram Razavi;Qing Li;Weiyi Toy

  • PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer

    Ana Bosch;Zhiqiang Li;Anna Bergamaschi;Haley Ellis

  • Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients

    Maurizio Scaltriti;Pieter J. Eichhorn;Javier Cortés;Ludmila Prudkin

  • Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence

    C Yang;Z Li;T Bhatt;M Dickler

  • Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.

    Qing-Bai She;Sarat Chandarlapaty;Qing Ye;Jose Lobo

  • Accelerating Discovery of Functional Mutant Alleles in Cancer

    Matthew T. Chang;Matthew T. Chang;Tripti Shrestha Bhattarai;Alison M. Schram;Craig M. Bielski

Frequent Co-Authors

José Baselga
José Baselga Memorial Sloan Kettering Cancer Center
Neal Rosen
Neal Rosen Memorial Sloan Kettering Cancer Center
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
David B. Solit
David B. Solit Memorial Sloan Kettering Cancer Center
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center
Clifford A. Hudis
Clifford A. Hudis Memorial Sloan Kettering Cancer Center
Larry Norton
Larry Norton Memorial Sloan Kettering Cancer Center
David M. Hyman
David M. Hyman Memorial Sloan Kettering Cancer Center
Mark E. Robson
Mark E. Robson Memorial Sloan Kettering Cancer Center
Edi Brogi
Edi Brogi Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your education in Biology and Biochemistry opens the door to diverse career paths. Many students choose to bridge their knowledge with health and wellness by pursuing an exercise science degree online, which focuses on human performance and physical health.

Similarly, a kinesiology online degree combines biology with the study of body movement, leading to roles in rehabilitation, sports science, or fitness training.

For those interested in healthcare careers, there are fast-tracked options like the shortest post master's pmhnp online programs, providing a pathway to become a Psychiatric Mental Health Nurse Practitioner. Alternatively, the shortest online nurse practitioner program offers a versatile transition into advanced nursing in a variety of clinical settings.

Exploring these online degrees and certification options can help you develop specialized skills and adapt to the evolving job market in science and healthcare.

Best Scientists Citing Sarat Chandarlapaty

Trending Scientists

Recently Published Articles